Principal Investigators

    K.Talbot, G.Haase



    Contact information of lead PI


    United Kingdom|France

    Title of project or programme

    Identifying effectors of mutant C9Orf72 ALS/FTD to combat neurodegeneration

    Source of funding information


    Total sum awarded (Euro)

    € 465,586

    Start date of award


    Total duration of award in years



    Research Abstract

    Hexanucleotide repeat expansions (HRE) are a type of genetic mutation. When they occur in the C9orf72 gene, they are the most frequent cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent studies have identified several different potential triggers of nerve cell death related to this type of genetic mutation, but the specific pathways leading to ALS/FTD remain to be discovered.

    The project aims to determine the pathways which trigger nereve damage by combining the power of studying human motor neurons grown in the lab, and other disease models including yeast and zebrafish. To identify and characterise potential neurodegeneration pathways we willl compare the expression of large numbers of genes in motor neurons grown from patients with C9orf72 HRE mutations, cells from such patients where the genetic mutation has been corrected, and age-matched healthy controls. We will then study these effects in more detail in yeast and test whether or not these pathways are good targets for drug therapy in a zebrafish model of ALS/FTD.

    In order to achieve these ambitious aims, we have gathered three leading European teams with documented expertise in the field of stem cell biology, ALS pathology and systems biology in this highly innovative and translational project.

    Further information available at:

Types: Investments < €500k
Member States: France, United Kingdom
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF